alphaveJAGSNPHARM₹233.84

Jagsonpal Pharmaceuticals Limited

₹ CrorePeersAMRUTANJAN NGLFINE SYNCOMF HESTERBIO SIGACHI LINCOLN WINDLASMcap ₹1,566 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	0.9	0.6	0.6	0.6
+ Goodwill	0.0	9.7	9.7	9.7
+ Other Intangibles	8.4	84.2	75.0	75.0
+ Other Non-current Financial Assets	5.2	17.4	85.1	85.1
Non-current Financial Assets	5.2	17.4	85.1	85.1
+ Deferred Tax Assets	1.2	0.8	0.1	0.1
+ Other Non-current Assets	2.1	4.4	3.1	3.1
Total Non-current Assets	17.8	117.1	173.6	173.6
Current Assets
+ Inventories	15.0	15.2	14.6	14.6
+ Trade Receivables	11.0	13.2	17.2	17.2
+ Cash & Cash Equivalents	12.8	11.2	10.0	10.0
+ Other Bank Balances	135.2	117.5	96.1	96.1
+ Other Current Financial Assets	0.1	0.1	0.1	0.1
Current Financial Assets	159.0	142.0	123.4	123.4
+ Other Current Assets	25.3	4.0	5.1	5.1
Total Current Assets	199.3	161.2	143.1	143.1
Total Assets	217.1	278.3	316.7	316.7
Equity
+ Equity Share Capital	13.2	13.3	13.4	13.4
+ Other Equity / Reserves	174.2	226.7	262.8	262.8
Equity — Owners of Parent	187.4	240.0	276.2	276.2
Total Equity	187.4	240.0	276.2	276.2
Liabilities
+ Other Non-current Financial Liab	7.6	8.7	6.6	6.6
Non-current Financial Liabilities	7.6	8.7	6.6	6.6
+ Provisions — Non-current	0.9	0.7	1.2	1.2
+ Deferred Tax Liabilities	2.1	3.1	4.4	4.4
Non-current Liabilities	10.5	12.4	12.2	12.2
+ Trade Payables	7.6	9.7	11.6	11.6
+ Other Current Financial Liab	8.1	12.0	12.3	12.3
Current Financial Liabilities	15.7	21.7	23.9	23.9
+ Provisions — Current	0.8	1.0	1.3	1.3
+ Current Tax Liabilities	0.0	0.0	0.6	0.6
+ Other Current Liabilities	2.7	3.2	2.5	2.5
Current Liabilities	19.1	25.9	28.3	28.3
Total Liabilities	29.7	38.3	40.5	40.5
Total Equity & Liabilities	217.1	278.3	316.7	316.7
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	1.5	2.4	2.4
+ Dues to Other Creditors — Current	—	8.3	9.2	9.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.